Display options
Cite
Izadi N, Najafi A, Saraei M. Metabolic syndrome and its determinants among professional drivers: a systematic review and meta-analysis. J Diabetes Metab Disord. 2021;20(2):2015-2023doi: 10.1007/s40200-021-00928-7.
Izadi, N., Najafi, A., & Saraei, M. (2021). Metabolic syndrome and its determinants among professional drivers: a systematic review and meta-analysis. Journal of diabetes and metabolic disorders, 20(2), 2015-2023. https://doi.org/10.1007/s40200-021-00928-7
Izadi, Nazanin, et al. "Metabolic syndrome and its determinants among professional drivers: a systematic review and meta-analysis." Journal of diabetes and metabolic disorders vol. 20,2 (2021): 2015-2023. doi: https://doi.org/10.1007/s40200-021-00928-7
Izadi N, Najafi A, Saraei M. Metabolic syndrome and its determinants among professional drivers: a systematic review and meta-analysis. J Diabetes Metab Disord. 2021 Nov 03;20(2):2015-2023. doi: 10.1007/s40200-021-00928-7. eCollection 2021 Dec. PMID: 34900837; PMCID: PMC8630342.
Copy Download .nbib Format: NLM
Share it on

J Diabetes Metab Disord. 2021 Nov 03;20(2):2015-2023. doi: 10.1007/s40200-021-00928-7. eCollection 2021 Dec.

Metabolic syndrome and its determinants among professional drivers: a systematic review and meta-analysis.

Journal of diabetes and metabolic disorders

Nazanin Izadi, Arezu Najafi, Maryam Saraei

Affiliations

  1. Occupational Sleep Research Center, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 34900837 PMCID: PMC8630342 DOI: 10.1007/s40200-021-00928-7

Abstract

BACKGROUND: Drivers are one of the trade unions that are most exposed to various health-related risks, especially metabolic diseases. The present study aimed to systematically assess the overall prevalence of metabolic syndrome and its determinants among drivers in the world.

METHODS: All retrospective, cross-sectional, or prospective studies evaluating the prevalence and risk for metabolic syndrome and its main components among male professional drivers were eligible for the initial assessment. PRISMA guideline was used. Two blinded reviewers independently screened the titles and abstracts of the manuscripts followed by a deep assessment of the full texts for determining the inclusion appropriateness.

RESULTS: In the final, 12 articles were eligible for the final analysis. Overall, 19,350 professional male drivers with a total average age of 43.06 years (ranged from 35.5 to 51.1 years) were included in the study. The prevalence of metabolic syndrome was estimated to be 32.8% (95%CI: 32.1% to 33.5%), and the major determinants of appearing this syndrome among professional drivers were advanced age, years of driving experience, higher body mass index, smoking, high cholesterol dietary regimen, high Framingham risk score, low regular exercising, history of diabetes mellitus, history of gout, and shift work pattern.

CONCLUSION: According to the 32.8% prevalence rate of metabolic syndrome among drivers, managerial measures are needed to prevent and control metabolic disturbances among professional drivers are recommended.

© This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021.

Keywords: Cardiovascular risk; Metabolic syndrome; Professional driver

Conflict of interest statement

Competing interestsNo potential conflicts of interest or funding source were related to this study.

References

  1. Vasc Health Risk Manag. 2009;5:731-43 - PubMed
  2. J Occup Health. 2005 Mar;47(2):89-95 - PubMed
  3. Occup Med (Lond). 2017 Jun 1;67(4):274-281 - PubMed
  4. Diabet Med. 2006 Apr;23(4):441-4 - PubMed
  5. Asia Pac J Clin Nutr. 2007;16(2):362-7 - PubMed
  6. Diabetes Care. 2010 Nov;33(11):2390-5 - PubMed
  7. J Med Assoc Thai. 2007 Sep;90(9):1908-15 - PubMed
  8. Ann Occup Environ Med. 2013 Nov 11;25(1):34 - PubMed
  9. Diabetes Care. 2003 Mar;26(3):575-81 - PubMed
  10. J Health Popul Nutr. 2017 Nov 13;36(1):36 - PubMed
  11. Arch Environ Health. 1999 Mar-Apr;54(2):71-8 - PubMed
  12. Work. 2020;67(4):829-835 - PubMed
  13. Int J Occup Med Environ Health. 2012 Sep;25(4):383-91 - PubMed
  14. Curr Hypertens Rep. 2018 Feb 26;20(2):12 - PubMed
  15. Arq Bras Endocrinol Metabol. 2008 Aug;52(6):1015-23 - PubMed
  16. J Diabetes Metab Disord. 2013 Jun 01;12(1):23 - PubMed
  17. Diabetol Metab Syndr. 2011 May 19;3(1):8 - PubMed
  18. Int J Hypertens. 2011;2011:821971 - PubMed
  19. Diabetes Res Clin Pract. 2007 Sep;77(3):471-8 - PubMed
  20. Acta Physiol (Oxf). 2014 Jul;211(3):515-27 - PubMed
  21. Lancet. 2005 Sep 24-30;366(9491):1059-62 - PubMed
  22. Diabetes Res Clin Pract. 2012 Apr;96(1):60-7 - PubMed
  23. G Ital Med Lav Ergon. 2012 Jul-Sep;34(3):352-9 - PubMed
  24. JAMA. 2002 Jan 16;287(3):356-9 - PubMed
  25. Circulation. 2003 Jul 29;108(4):420-5 - PubMed
  26. Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S46-51 - PubMed
  27. Int Arch Occup Environ Health. 2003 Jul;76(6):424-30 - PubMed
  28. J Occup Environ Med. 2020 Jul;62(7):453-459 - PubMed
  29. Int J Epidemiol. 1987 Jun;16(2):208-14 - PubMed
  30. J Clin Epidemiol. 2009 Oct;62(10):e1-34 - PubMed
  31. Obes Rev. 2018 Jan;19(1):28-40 - PubMed
  32. Diabet Med. 2006 May;23(5):469-80 - PubMed
  33. Lancet. 2001 Oct 6;358(9288):1147-53 - PubMed
  34. Pan Afr Med J. 2020 Jun 29;36:136 - PubMed
  35. Int J Mol Sci. 2013 Nov 06;14(11):21997-2010 - PubMed
  36. Cardiovasc J Afr. 2018 Mar/Apr 23;29(2):106-114 - PubMed
  37. Arch Intern Med. 2003 Feb 24;163(4):427-36 - PubMed
  38. J Am Geriatr Soc. 2006 Sep;54(9):1317-24 - PubMed
  39. Rev Salud Publica (Bogota). 2017 Jul-Aug;19(4):499-505 - PubMed

Publication Types